AHPA opposes Dietary Supplement Listing Act of 2026

• By: AHPA
• On: 01/16/2026 13:56:23
• In: Regulation / Legislation

January 16, 2026

The American Herbal Products Association (AHPA) announces its opposition to the latest iteration of Senator Dick Durbin's (D-IL) Dietary Supplement Listing Act, introduced by the retiring senator in the 119th Congress yesterday. The bill seeks to establish a mandatory product listing (MPL) requirement for dietary supplements marketed in the United States. Senator Durbin previously introduced similar MPL legislation in both the 117th and 118th Congresses to opposition from AHPA and other industry trade groups.
 
Advocates for MPL have not sufficiently articulated how this requirement would provide tangible benefits to consumers or meaningfully enhance FDA's existing authorities to enforce against marketers of drug-spiked products masquerading as dietary supplements. While not opposed to the concept of mandatory product listing in principle, AHPA does not support legislation that lacks provisions to clearly benefit public health or sufficiently accommodate small businesses. AHPA has long supported statutory amendments to the Federal Food, Drug, and Cosmetic Act that protect consumers without placing undue burdens on responsible manufacturers.
 
“AHPA remains committed to protecting public health and fostering a transparent, innovative dietary supplement industry,” said AHPA President & CEO Graham Rigby. “We will continue our direct engagement with FDA and Congress to develop meaningful, common-sense reforms that increase accountability and modernize our regulatory framework to meet the needs of today's dietary supplement marketplace and consumers.”